# High-Density Lipoprotein (HDL) Treatment Study

> **NCT00458055** · NA · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 19 (actual)

## Conditions studied

- Coronary Arteriosclerosis
- Hypoalphalipoproteinemias
- Genetic Diseases, Inborn

## Interventions

- **DRUG:** Atorvastatin; Fenofibrate; Niacin

## Key facts

- **NCT ID:** NCT00458055
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458055, "High-Density Lipoprotein (HDL) Treatment Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00458055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*